Modified early intensive and treat-and-extend regimen of anti-vascular endothelial growth factor for diabetic macular edema in Taiwan. [PDF]
Chou JF, Wu JS, Chen YL, Chen SN.
europepmc +1 more source
Background A post hoc analysis of the STAR study, which was a 48-week, phase IV, multicenter randomized controlled multicenter clinical trial was performed. This study aims to identify the baseline factors associated with visual and anatomic changes over
Tsung-I. Wang +6 more
doaj +1 more source
Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion. [PDF]
Gildea D, Tang B, Baily C, Ryan A.
europepmc +1 more source
Draft a protocol for an observational study for anti-VEGF therapy in age related macular degeneration [PDF]
Μακρή, Όλγα
core +1 more source
Keiko Azuma,1 Ryo Asaoka,1 Aya Matsuda,2 Jihee Lee,3 Kimiko Shimizu,1 Hiroko Inui,1 Hiroshi Murata,1 Asako Ogawa,1 Motoshi Yamamoto,1 Tatsuya Inoue,1 Ryo Obata1 1Department of Ophthalmology, Graduate School of Medicine and Faculty of Medicine, The ...
Azuma K +10 more
doaj
Early detection of age related macular degeneration: current status [PDF]
core +1 more source
Clinical outcome using a modified treat-and-extend protocol for neovascular age-related macular degeneration. [PDF]
Vofo BN, Cnaany Y, Chowers I.
europepmc +1 more source
Multimodal imaging biomarkers associated with recurrence of diabetic macular edema during aflibercept treat-and-extend therapy. [PDF]
Kim K, Lee J, Choi J, Yu SY.
europepmc +1 more source
Efficacy of a Modified Treat-and-Extend Aflibercept Regimen for Macular Oedema in Eyes with Central Retinal Vein Occlusion: 2-Year Prospective Study. [PDF]
Arai Y +6 more
europepmc +1 more source
Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis. [PDF]
Nichani PAH +5 more
europepmc +1 more source

